Clinical Trial Update: Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Firebird 2 and Excel sirolimus-eluting stents in real-world coronary artery disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Excel (sirolimus-eluting stent)
• Firebird 2 (sirolimus-eluting stent)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN